机构

• 上海药物研究所 [8]
• 高能物理研究所 [1]

采集方式

• OAI收割 [8]
• iSwitch采集 [1]

内容类型

• 期刊论文 [9]

发表日期

• 2023 [2]
• 2021 [3]
• 2020 [1]
• 2017 [2]
• 2016 [1]

学科主题

筛选

浏览/检索结果: 共9条，第1-9条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 14 作者:  Pei, Jin-peng;  Wang, Yue;  Ma, Lan-ping;  Wang, Xin;  Liu, Liang   |  收藏  |  浏览/下载：31/0  |  提交时间：2023/04/10 AXL  NSCLC  TNBC  M2-macrophage  antibody-drug conjugate   Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo 期刊论文  OAI收割 JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 1, 页码: 152-162 作者:  Lai, Mengzhen;  Zhang, Tao;  Chen, Hao   |  收藏  |  浏览/下载：120/0  |  提交时间：2023/04/10 fourth-generation EGFR inhibitor  EGFRC797S mutation  NSCLC  drug resistance  small molecular inhibitor   LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo 期刊论文  OAI收割 CANCER SCIENCE, 2021, 页码: 12 作者:  Liu, Yingqiang;  Lai, Mengzhen;  Li, Shan;  Wang, Yanan;  Feng, Fang   |  收藏  |  浏览/下载：108/0  |  提交时间：2022/01/18 C797S  epidermal growth factor receptor  fourth-generation EGFR TKI  non-small cell lung cancer  osimertinib resistance   BCL9 regulates CD226 and CD96 checkpoints in CD8(+) T cells to improve PD-1 response in cancer 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 卷号: 6, 期号: 1, 页码: 14 作者:  Feng, Mei;  Wu, Zhongen;  Zhou, Yan;  Wei, Zhuang;  Tian, Enming   |  收藏  |  浏览/下载：57/0  |  提交时间：2021/11/04 Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy 期刊论文  OAI收割 BRITISH JOURNAL OF PHARMACOLOGY, 2021, 页码: 20 作者:  Liu, Chenglong;  Zhou, Feilong;  Yan, Ziqin;  Shen, Lian   |  收藏  |  浏览/下载：44/0  |  提交时间：2021/06/11 immunotherapy  PD-1/PD-L1  TGF-beta  tumour immune microenvironment   Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function 期刊论文  OAI收割 MOLECULAR CANCER THERAPEUTICS, 2020, 卷号: 19, 期号: 11, 页码: 2340-2352 作者:  Jin, Rui;  Liu, Liang;  Xing, Yun;  Meng, Tao;  Ma, Lanping   |  收藏  |  浏览/下载：69/0  |  提交时间：2020/12/24 Search for a scalar partner of the top quark in the jets plus missing transverse momentum final state at root s=13 tev with the atlas detector 期刊论文  iSwitch采集 Journal of high energy physics, 2017, 期号: 12, 页码: 56 作者:  Aaboud, M.;  Aad, G.;  Abbott, B.;  Abdinov, O.;  Abeloos, B. 收藏  |  浏览/下载：134/0  |  提交时间：2019/04/23 Hadron-hadron scattering (experiments)   Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma 期刊论文  OAI收割 ONCOTARGET, 2017, 卷号: 8, 期号: 35, 页码: 59086-59102 作者:  Zhang, Xuesai;  Li, Qingrou;  Zhao, Hui;  Ma, Lanping;  Meng, Tao   |  收藏  |  浏览/下载：41/0  |  提交时间：2019/01/08 tissue factor  triple negative breast cancer  pancreatic adenocarcinoma  metastasis  antibody-drug conjugate   Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer 期刊论文  OAI收割 ONCOTARGET, 2016, 卷号: 7, 期号: 41, 页码: 67071-67086 作者:  Qian, Jianchang;  Chen, Yaqing;  Meng, Tao;  Ma, Lanping;  Meng, Lanfang   |  收藏  |  浏览/下载：43/0  |  提交时间：2019/01/08 mTOR kinase inhibitor  mTORC2  apoptosis  lipid metabolism